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439* Implementation, uptake and impact of a cystic ﬁbrosis electronic
patient record system
D. Peckham1, H. White1, A. Morton1, K. Pollard1, C. Etherington1, P. Whitaker1,
S.P. Conway1, K.G. Brownlee1, T.W. Lee1, J. Taylor1. 1Regional Cystic Fibrosis
Unit, Leeds, United Kingdom
In 2007, we introduced a cystic ﬁbrosis (CF) electronic patient record (EPR)
system (modiﬁed EMIS PCS). We report the results of a staff survey investigating
implementation, uptake and impact of EPR on clinical work and delivery of care.
The survey was based on a modiﬁed questionnaire by Laerum et al, (2004) with
sections covering computer experience, access to hardware, reliability of software,
assessment and satisfaction of all aspects of EPR and perceived impact on the unit’s
performance.
A total of 27 members of the multidisciplinary team responded (8 doctors, 4
nurses, 2 health care assistants, 3 dietitians, 4 secretaries, 5 physiotherapists and a
pharmacist). Despite 18 staff having no prior experience with EPR, nobody wished
to return to paper records. Most felt that the unit could and should move away from
paper records as duplication was one of the commonest complaints. Success of EPR
was rated as excellent, good and fair by 12, 13 and 2 people respectively. Over
50% felt that EPR had improved the quality of work. Areas where performance had
been made signiﬁcantly easier included, automatic letter generation, ease of access-
ing information and graphical representation of serial measurements. Importantly
>90% of clinical staff felt that the system helped identify clinical deterioration
sooner with 100% of all responders reporting improved communication between
the MDT.
EPR has been successfully integrated into our unit, with members of the MDT
reporting signiﬁcant beneﬁts. EPR was felt to be a very positive move forward and
has the potential to improve both the quality and the effectiveness of care. Results
of this survey will have direct impact on improving the next generation of EPR due
to be launched later in 2009.
440 Anatomopathological changes in dead children with cystic
ﬁbrosis
S. Sciuca1, O. Turcu1, V. Petrovici1. 1Pediatric pulmonology, State Medical and
Pharmaceutical University, Chisinau, Moldova
Aim: To study the most common changes of the internal organs and the most
frequents complications that caused the death of the children with cystic ﬁbrosis
(CF).
Material and methods: This study includes a retrospective review of the dead CF
children medical documents for 12 years (from 1995 till present).
Results: In this time age had died 31 children and on the autopsy was conﬁrmed
CF. The lifetime CF diagnosis based on compatible clinical and laboratory ﬁndings
in 12 children (38.7%) was established. Eight children (25.8%) had complicated
meconium ileus that caused the death in newborn period. A deﬁnitive ﬁnal diagnosis
could not be recognized in 11 cases (35.5%) with severe lung infection and
septicaemia. Most of children (87.1%) has died during the ﬁrst year of the life,
2 children lived till 2−3 years, 1 child − 12 years and 1 child − 17.5 years.
The anatomopathological diagnostic of CF in all this children was established
by macroscopic and histopathologic examine which revealed the characteristic
changes. The dominant pathological changes were ﬁnding in pancreas and were
present in all children died of CF. Anatomopathological examination of the pancreas
revealed ﬁbrosis and atrophy of the pancreatic tissue and cystic dilatation of
glands ducts. Pulmonary infection (bronchitis, pneumonia) were discovered in
90.3% cases. Hepatic steatosis was a common ﬁnding during anatomopathological
examines ( 12 cases). Pathological changes in CF have progressed with the degree
of malnutrition in deceased children.
Conclusion: The most common anatomopathological changes in CF children were
found in the respiratory system and pancreas, by implication of exocrine glands
ducts. Death occurred by meconium ileus in neonates, or by developing infectious
complications in older children.
441 New method for charting pulmonary function history
Y.W. Lee1, J. Lee1, W.J. Warwick1. 1Pediatrics, University of Minnesota,
Minneapolis, MN, USA
Three year periods of PFT results are used by CF centers to review the recent
clinical course of patients’ lung disease. As the life expectancy of CF patients
increases, the history is ignored as attention focused on recent events. Ignoring
the lifelong PFT history reduces the possibility of identifying changes in treatment
or other factors that are still active and may need new treatment. We suggest a
graphing technique for presenting lifelong PFT data.
All PFT results were used to generate the chart of percent predicted FEV1 and FVC
for CF patients. Since recently most of CF patients start the PFT around age three,
mixed prediction equations covering age 3 to 80 were used to calculate composite
percent predicted values of FEV1 and FVC. The overview graph displayed upper
right hand corner of the main graph shows age up to 80. The hospitalization,
showing greater drop of FEV1 generally, is displayed as a vertical bar at the bottom
of the abscissa. We used calendar year with age on the abscissa.
The chart could show
– Treatment Effect during Hospitalization: The FEV1 can be compared between
before and after hospitalization.
– Identiﬁcation of PFT pattern: It is possible that the change of FEV1 is caused
by whether the long or short term effect from the trend of FEV1.
– In the abscissa, the calendar year and age are displayed simultaneously. It is
helpful to understand external factors such as new treatment and environmental
change.
This charting technique is designed to raise questions about the clinical courses
and treatments by patients, parents, as well as, physicians, respiratory therapists,
nurses, and social workers. The questions that we hope will be asked related to
medicines, season, changes in the families, changes in the treatments to increase
the collaboration will guide them for the treatments of acquired health problems.
442 Outreach clinics for the provision of specialist cystic ﬁbrosis
(CF) care to remote areas
S.J. Doe1, A. Anderson1, K. Stavers1, K. Heslop1, S. Johnston1, M. Caraher1,
S.J. Bourke1. 1Adult CF Centre, Royal Victoria Inﬁrmary, Newcastle upon Tyne,
United Kingdom
Background: Specialist care in a regional Centre improves outcome for patients
with CF. Access to a Centre is difﬁcult for patients in remote areas. Cumbria
does not have adult CF services, patients travel to Newcastle. We established an
outreach clinic whereby the CF team travels to Cumbria. The service was evaluated
by patients and the team.
18 (8.7%; mean age 25.4 (18−67) yrs) of 208 patients attend the outreach clinic.
14 have Pseudomonas infection. Mean FEV1 is 2.65 L (74%) (1.44 L (44%)-4.19 L
(108%)); mean BMI is 20.7 (16.4−25.1). Patients are happy with outreach care:
9 (50%) prefer this setting, 7 (39%) like some care in outreach and some in the
Centre, 1 (5%) prefers all care at the CF Centre, and 1 (5%) is unsure. All are
happy to attend the CF Centre when needed. Outreach clinics reduce mean traveling
distance from 86 to 27 miles and travelling time by a mean of 131 mins. No speciﬁc
problems were identiﬁed with outreach care. For the 7 members of the CF team,
outreach clinics involve extra preparatory work (range 0−4.5 hrs) and travel time
(3 hrs). Although full clinical assessment and IV antibiotics are undertaken in
the outreach clinic, facilities are considered less good. Flexibility in scheduling
visits and segregation of patients are difﬁcult. All recognize outreach as helpful for
patients in providing care closer to home.
Conclusions: Outreach care is popular with patients and allows some care to be
delivered closer to home by the CF team. The team is keen to provide this service
but recognize constraints on what can be done in an outreach clinic. Patients need
access to the CF Centre for inpatient care, annual reviews and complex procedures.
Outreach care involves more work and time for the CF Team.
